Market Overview The rituximab biosimilars market is experiencing growth as biosimilar manufacturers create cost-effective alternatives to this important monoclonal antibody. The global market is projected to exceed USD 5.8 billion through 2030, driven by patient access expansion, cost reduction emphasis, and regulatory approval acceleration. Current Market Landscape Rituximab biosimilar...